TY - JOUR
TI - COST-EFFECTIVENESS ANALYSIS OF ATEZOLIZUMAB COMPARED TO TREATMENT
OPTIONS FOR ADULT PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL
CELL LUNG CANCER (NSCLC) AFTER PRIOR CHEMOTHERAPY - UPDATED RESULTS
AU - Kourkoulas, N.
AU - Athanasakis, K.
AU - Kakouros, M.
AU - Skroumpelos, A.
AU - and Kyriopoulos, J.
JO - Value in Health
PY - 2018
VL - 21
TODO - 3
SP - S39-S40
PB - EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC
SN - 1098-3015, 1524-4733
TODO - 10.1016/j.jval.2018.09.231
TODO - null
TODO - null
ER -